• Substance P: An Interference-Aware Research Guide

  2026-08-31

  Explore Substance P as a tachykinin neuropeptide through an interference-aware framework for pain transmission research, receptor assays, and inflammation studies. This guide connects peptide handling and biological interpretation with lessons from modern spectral classification and machine-learning workflows.

• Thiothixene for Macrophage Efferocytosis Studies

  2026-08-31

  Thiothixene is more than a typical antipsychotic agent: it provides a practical probe for studying macrophage efferocytosis, dopamine signaling pathway modulation, and vitamin A–linked clearance biology. This guide connects a 2 μM in vitro starting condition with assay design, controls, troubleshooting, and pharmacokinetic context.

• Arsenic, MMPs, and Blood–Brain Barrier Injury

  2026-08-30

  A 2024 mouse study links chronic sodium arsenite exposure to impaired learning and memory through MMP-2/MMP-9-associated blood–brain barrier disruption and hippocampal neuronal apoptosis. Its combined behavioral, structural, permeability, and pharmacological evidence positions doxycycline hyclate as a useful mechanistic probe while underscoring the limits of inferring causality from inhibitor rescue alone.

• β-Pseudouridine for RNA Modification Workflows

  2026-08-29

  β-Pseudouridine supports controlled studies of RNA structure, modification status, and translational fidelity. This workflow-focused guide shows how to use it as an analytical control, a mechanistic probe, and a comparator in modified-RNA and self-amplifying RNA experiments without over-attributing platform effects.

• Acridine Orange hydrochloride: Practical Guide

  2026-08-28

  Acridine Orange hydrochloride provides a dual-emission approach for nucleic acid visualization in intact-cell cytochemistry and flow workflows, helping distinguish green and red fluorescence associated with different nucleic acid states. It should be optimized with assay-specific controls and should not be treated as a standalone proof of apoptosis, transcriptional activity, or DNA/RNA identity.

• NVP-BGJ398 Phosphate: Translational FGFR Strategy

  2026-08-28

  NVP-BGJ398 phosphate offers a research framework for connecting FGFR1–3 biology with genotype-selected cancer models and FGFR3-driven skeletal disease. This article moves beyond product specifications to show how pathway pharmacology, tissue-level validation, and translational study design can be integrated.

• CFDA-SE Workflows for Proliferation and Migration

  2026-08-28

  CFDA-SE turns intracellular esterase activity into a division-sensitive fluorescent record for viable cells. This practical guide shows how to combine proliferation history with migration and surfaceome experiments without confusing a phenotypic readout with a molecular interaction map.

• EPI-001: Androgen Receptor N-Terminal Inhibition

  2026-08-27

  EPI-001 is an androgen receptor N-terminal domain inhibitor for studying ligand-dependent and ligand-independent signaling in prostate cancer, CRPC, and selected AR/ARv7-positive models. This practical guide connects formulation, dose-response, migration, molecular readouts, and troubleshooting to help distinguish pathway inhibition from nonspecific cytotoxicity.

• Z-WEHD-FMK in Caspase-1 Research

  2026-08-26

  Z-WEHD-FMK, also known as Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK, is a cell-permeable irreversible inhibitor of inflammatory caspases. Its documented use in Chlamydia-infected HeLa cells provides a practical starting point for studying caspase signaling, Golgi fragmentation, pyroptosis, and host–pathogen interactions.

• From Cholesterol Mapping to Fibrosis Mechanism

  2026-08-26

  Filipin III can connect membrane cholesterol biology with translational questions in PHMG-induced pulmonary fibrosis. By pairing cholesterol-sensitive imaging with the reported SOAT1–lipophagy–foam-cell mechanism, researchers can move beyond descriptive lipid staining toward spatially resolved, experimentally testable disease biology.

• Single-Cell Ciprofloxacin–Tetracycline Antagonism

  2026-08-26

  The reference study uses microfluidic single-cell analysis to show that tetracycline weakens ciprofloxacin activity primarily by increasing survival among cells exposed to the combination. Its growth-dependent SOS analysis identifies distinct dying subpopulations, clarifying why nutrient conditions reshape antibiotic antagonism.

• Sodium Salicylate: NF-κB Control in Tumor Stroma

  2026-08-25

  A translational framework for using sodium salicylate as a mechanistic NF-κB inhibitor in pancreatic tumor microenvironment studies, with practical guidance for separating inflammatory signaling from physical stromal remodeling.

• Vidarabine Monohydrate: From Mechanism to Translation

  2026-08-24

  A translational framework for using Vidarabine monohydrate as a mechanism-led antiviral research compound, with practical guidance for solubility, assay design, herpes simplex virus research, and evidence-based development decisions.

• Leupeptin Hemisulfate: A Better Assay Control

  2026-08-24

  Leupeptin hemisulfate salt is a reversible competitive protease inhibitor with broad utility in protein degradation and cell biology workflows. This guide explains how to deploy Leupeptin as a proteostasis-control reagent alongside modern TET2 metabolite-binding assays without confusing sample preservation with direct enzyme regulation.

• Apicidin Disrupts Oocyte Maturation and Acetylation

  2026-08-23

  The reference study shows that Apicidin exposure compromises oocyte quality by delaying meiotic maturation, disturbing spindle and actin organization, and altering histone and tubulin acetylation. Its in vitro design links meiotic apparatus defects with HDAC1/HDAC3 expression changes, DNA damage, and early apoptosis, providing a mechanistic framework for reproductive toxicology studies.

8543 records 1/570 page Next 12345 下5页 Last page